Sales rise 31.30% to Rs 91.08 crore
Net Loss of Astec Lifesciences reported to Rs 33.04 crore in the quarter ended June 2025 as against net loss of Rs 39.72 crore during the previous quarter ended June 2024. Sales rose 31.30% to Rs 91.08 crore in the quarter ended June 2025 as against Rs 69.37 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 91.08 | 69.37 | 31 |
OPM % | -12.07 | -66.67 | - |
PBDT | -21.52 | -52.37 | 59 |
PBT | -33.02 | -61.64 | 46 |
NP | -33.04 | -39.72 | 17 |
Powered by Capital Market - Live News